Published in J Nucl Cardiol on January 22, 2001
Prognostic value of nitrate enhanced Tc99m MIBI SPECT study in detecting viable myocardium in patients with coronary artery disease. Int J Cardiovasc Imaging (2003) 1.40
Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium. Eur J Nucl Med Mol Imaging (2004) 0.93
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against. Eur J Nucl Med Mol Imaging (2005) 0.75
Multi-modality imaging for assessment of myocardial viability? Int J Cardiovasc Imaging (2007) 0.75
Depressed Exercise Peak Ejection Rate Detected on Ambulatory Radionuclide Monitoring Reflects End-Stage Cardiac Inotropic Reserve and Predicts Mortality in Ischaemic Cardiomyopathy. Cardiol Res (2012) 0.75
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging (2005) 3.61
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation (1991) 2.06
Sympathetic deactivation by growth hormone treatment in patients with dilated cardiomyopathy. Eur Heart J (1998) 2.05
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI. J Nucl Med (1993) 1.65
Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med (1997) 1.54
Bipartite substrate discrimination by human nucleotide excision repair. Proc Natl Acad Sci U S A (1997) 1.52
Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab (2001) 1.51
Effects of myocardial revascularization on regional thallium-201 uptake and systolic function in regions with reverse redistribution on tomographic thallium-201 imaging at rest in patients with chronic coronary artery disease. J Nucl Cardiol (1998) 1.45
Thallium-201 reverse redistribution at reinjection imaging correlated with coronary lesion, wall motion abnormality and tissue viability. J Nucl Med (1996) 1.41
The regulatory background of nuclear cardiology in Europe: a survey by the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging (2006) 1.39
Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction. J Nucl Cardiol (1998) 1.38
Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. Am Heart J (1999) 1.23
Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. J Clin Endocrinol Metab (1999) 1.17
Gastrointestinal manifestations in children with cerebral palsy. Brain Dev (1999) 1.16
Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study. Heart (2009) 1.07
Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab (2000) 1.04
Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1996) 1.02
Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation (1994) 0.97
The chemistry of single-stranded 4'-DNA radicals: influence of the radical precursor on anaerobic and aerobic strand cleavage. Chem Biol (1995) 0.96
Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med (1998) 0.95
Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med (1996) 0.95
Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med (1995) 0.91
Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. J Clin Endocrinol Metab (2001) 0.91
Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly. J Clin Endocrinol Metab (2000) 0.91
Intensive training and cardiac autonomic control in high level athletes. Med Sci Sports Exerc (1998) 0.90
Prevalence and prognostic significance of silent myocardial ischaemia detected by exercise test and continuous ECG monitoring after acute myocardial infarction. Eur Heart J (1991) 0.90
Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol (Oxf) (1998) 0.89
Misalignment between PET transmission and emission scans: its effect on myocardial imaging. J Nucl Med (1992) 0.87
An overview of radiotracers in nuclear cardiology. J Nucl Cardiol (2000) 0.87
Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. Am J Physiol (1994) 0.87
Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol (1998) 0.87
Myocardial hypertrophy and left ventricular diastolic function in hypertensive patients: an echo Doppler evaluation. Eur Heart J (1989) 0.86
Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease. Clin Genet (2004) 0.86
Site-specific DNA substrates for human excision repair: comparison between deoxyribose and base adducts. Chem Biol (1996) 0.85
FGD-PET in the follow-up of recurrent colorectal cancer. Colorectal Dis (2003) 0.84
Impaired cardiac performance in elderly patients with growth hormone deficiency. J Clin Endocrinol Metab (1999) 0.84
Reverse redistribution in resting thallium-201 myocardial scintigraphy in chronic coronary artery disease: an index of myocardial viability. J Nucl Med (1995) 0.83
DNA synthesis arrest at C4'-modified deoxyribose residues. Biochemistry (1997) 0.83
Comparison of the antihypertensive activities of xipamide and chlorthalidone: a double-blind, randomized, crossover trial. Curr Med Res Opin (1981) 0.83
Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. J Hum Hypertens (2005) 0.83
Radionuclide monitoring of left ventricular function after sublingual nifedipine administration at rest and during moderate physical activity. J Nucl Cardiol (2001) 0.83
Accuracy and repeatability of left ventricular systolic and diastolic function measurements using an ambulatory radionuclide monitor. Eur J Nucl Med (1992) 0.83
Cardiac magnetic resonance imaging illustrating Anderson-Fabry disease progression. Br J Radiol (2010) 0.82
Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging. J Nucl Med (1998) 0.82
Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study. J Clin Endocrinol Metab (1999) 0.81
Left ventricular systolic and diastolic function measurements using an ambulatory radionuclide monitor: effects of different time averaging on accuracy. J Nucl Med (1993) 0.81
Repeatability of haemodynamic responses to cardiac stimulations by ambulatory monitoring of left ventricular function. J Nucl Biol Med (1993) 0.81
Reverse redistribution in resting thallium-201 myocardial scintigraphy in patients with coronary artery disease: relation to coronary anatomy and ventricular function. J Nucl Med (1993) 0.80
Gender- and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest (2002) 0.80
Identification of viable myocardium in patients with chronic coronary artery disease using rest-redistribution thallium-201 tomography: optimal image analysis. J Nucl Med (1998) 0.80
Cardiac autonomic responses to volume overload in normal subjects and in patients with dilated cardiomyopathy. Am J Physiol (1999) 0.80
Detection of pericardial effusion during Tc-99m MIBI parathyroid imaging in a patient with chronic renal failure. Clin Nucl Med (1996) 0.80
New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer. Q J Nucl Med Mol Imaging (2015) 0.80
Stable improvement in large artery compliance after long-term antihypertensive treatment with enalapril. Am J Hypertens (1988) 0.79
The diagnosis of nonfunctioning pheochromocytoma. The role of I-123 MIBG imaging. Clin Nucl Med (1995) 0.79
Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study. Clin Endocrinol (Oxf) (2000) 0.79
Effects of coronary occlusion on arterial baroreflex control of heart rate and vascular resistance. Am J Physiol (1987) 0.79
Vagal mediation of the effects of atrial natriuretic factor on blood pressure and arterial baroreflexes in the rabbit. Circ Res (1987) 0.79
Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents. Circulation (1985) 0.79
Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment. Mol Aspects Med (1994) 0.79
Converting enzyme inhibition, heart rate variability, and myocardial infarction. Am J Cardiol (1996) 0.78
Reflex control of coronary vascular tone by cardiopulmonary receptors in humans. J Am Coll Cardiol (1988) 0.78
Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med (1995) 0.78
Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction. J Am Coll Cardiol (1990) 0.78
Effects of sustained training on left ventricular structure and function in top level rowers. Eur Heart J (1993) 0.78
Carotid sinus reflex control of coronary blood flow in human subjects. J Am Coll Cardiol (1985) 0.78
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. Am J Cardiol (1996) 0.78
Ouabain-induced reflex coronary vasodilatation mediated by cardiac receptors. Am J Physiol (1984) 0.78
Cardiological aspects of growth hormone and insulin-like growth factor-I. J Pediatr Endocrinol Metab (1998) 0.78
Left ventricular remodelling in the year after myocardial infarction: an echocardiographic, haemodynamic, and radionuclide angiographic study. Coron Artery Dis (1994) 0.78
Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring. Drugs (1988) 0.78
Diltiazem in the treatment of mild or moderate essential hypertension. Comparison with metoprolol in a crossover double-blind trial. J Clin Pharmacol (1984) 0.78
Effects of intravenous verapamil administration on left ventricular diastolic function in systemic hypertension. Am J Cardiol (1987) 0.78
Ambulatory monitoring of left ventricular function during cardiopulmonary exercise tests in normal sedentary subjects. J Nucl Med (1995) 0.78
Prediction of recovery of left ventricular dysfunction after acute myocardial infarction: comparison between 99mTc-sestamibi cardiac tomography and low-dose dobutamine echocardiography. J Nucl Med (1999) 0.78
Influence of reversible segmental left ventricular dysfunction on heart period variability in patients with one-vessel coronary artery disease. J Am Coll Cardiol (1994) 0.77
Late phase of nitroglycerin-induced coronary vasodilatation blunted by inhibition of prostaglandin synthesis. Circulation (1985) 0.77
[Relationship between exercise capacity and left ventricular function at rest in patients with heart insufficiency: radionuclide continuous monitoring of left ventricular function]. Radiol Med (2000) 0.77
Ambulatory monitoring of left ventricular function: walk and bicycle exercise in congestive heart failure. J Nucl Med (1997) 0.77
Effects of converting enzyme inhibition on baroreflex sensitivity in patients with myocardial infarction. J Am Coll Cardiol (1992) 0.77
Cardiovascular aspects in acromegaly: effects of treatment. Metabolism (1996) 0.77
Radionuclide monitoring of cardiac adaptations to volume loading in patients with dilated cardiomyopathy and mild heart failure. Effects of angiotensin-converting enzyme inhibition. Circulation (1995) 0.77
Cardiac performance during exercise in patients with Fabry's disease. Eur J Clin Invest (2008) 0.76
The widened use of exogenous stimulation with recombinant human TSH to treat metastatic thyroid carcinoma in Italy. Q J Nucl Med Mol Imaging (2012) 0.76
Gated SPECT myocardial perfusion imaging: the further improvements of an excellent tool. Q J Nucl Med Mol Imaging (2010) 0.76
Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy. J Clin Endocrinol Metab (1996) 0.76
Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction. Am J Cardiol (1997) 0.76
Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: comparison with digitalis. J Am Coll Cardiol (1992) 0.76
Reversal of left ventricular hypertrophy following treatment with beta-blockers: experience with tertatolol. Am J Nephrol (1986) 0.76
Assessment of left ventricular function by ECG-gated myocardial perfusion scintigraphy with image inversion technique: comparison with equilibrium radionuclide angiography. J Nucl Cardiol (2000) 0.76
Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection. J Nucl Cardiol (1999) 0.76
Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab (1994) 0.76
Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study. Eur J Clin Pharmacol (1997) 0.76
Beta blockers and left ventricular hypertrophy in hypertension. Am Heart J (1987) 0.76
Technetium 99m furifosmin regional myocardial uptake in patients with previous myocardial infarction: relation to thallium-201 activity and left ventricular function. J Nucl Cardiol (2000) 0.75